AMENDMENT TO CONSULTING AGREEMENTConsulting Agreement • August 1st, 2007 • Lipid Sciences Inc/ • Biological products, (no disgnostic substances)
This Amendment to Consulting Agreement (this “Agreement”) is made effective as of July 31, 2007 (the “Effective Date”) and is between Washington Cardiovascular Associates, LLC, a Maryland limited liability company (“WCA”), H. Bryan Brewer, Jr., M.D. (“Consultant”), and Lipid Sciences, Inc., a Delaware corporation (the “Corporation”).
